COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 729: Articles 7281-7290  | Next

COVID-19 vaccine effectiveness against mortality and risk of death from other causes after COVID-19 vaccination, the Netherlands, January 2021- January 2022
de Gier, B., van Asten, L., Boere, T., van Werkhoven, H., van Roon, A., van den Ende, C., Hahne, S., de Melker, H., Knol, M., van den Hof, S.
10.1101/2022.07.21.22277831 — Posted: 2022-07-22
Decoding the Effects of Spike Receptor Binding Domain Mutations on Antibody Escape Abilities of Omicron Variants
Chakraborty, S., Saha, A., Saha, C., Ghosh, S., Mondal, T.
10.1101/2022.07.21.500931 — Posted: 2022-07-22
Suppression of systemic T cell immunity to viral infection during liver injury is prevented by inhibition of interferon and IL-10 signaling
Hackstein, P. C., Spitzer, J., Symeonidis, K., Horvatic, H., Bedke, T., Steglich, B., Assmus, L., Odainic, A., Kessler, N., Klein, S., Beyer, M., Schmithausen, R., Latz, E., Kurts, C., Trebicka, J., Flavell, R., Garbi, N., Roers, A., Huber, S., Schmidt, S., Knolle, P., Abdullah, Z.
10.1101/2022.07.21.501031 — Posted: 2022-07-22
Learning from pre-pandemic data to forecast viral antibody escape
Thadani, N. N., Gurev, S., Notin, P., Youssef, N., Rollins, N. J., Sander, C., Gal, Y., Marks, D.
10.1101/2022.07.21.501023 — Posted: 2022-07-22
Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
QU, P., Faraone, J. N., Evans, J. P., Zheng, Y.-M., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., Liu, S.-L.
10.1101/2022.07.21.501010 — Posted: 2022-07-22
A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits protective immunity in domestic cats
Conforti, A., Sanchez, E., Salvatori, E., Lione, L., Compagnone, M., Pinto, E., Palombo, F., Sun, Y., Viscount, B., Hayward, J., Shorrock, C., Diel, D. G., Impellizeri, J. A., Aurisicchio, L.
10.1101/2022.07.20.500860 — Posted: 2022-07-22
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without Omicron breakthrough infection.
Planas, D., Staropoli, I., Porrot, F., Guivel-Benhassine, F., Handala, L., Prot, M., Bolland, W. H., Puech, J., Pere, H., Veyer, D., Seve, A., Simon-Loriere, E., Bruel, T., prazuck, t., Stefic, K., Hocqueloux, L., Schwartz, O.
10.1101/2022.07.22.22277885 — Posted: 2022-07-22
Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves
Bingham, J., Tempia, S., Moultrie, H., Viboud, C., Jassat, W., Cohen, C., Pulliam, J. R. C.
10.1101/2022.07.22.22277932 — Posted: 2022-07-22
Years of Life Lost in the US During the COVID-19 Pandemic, March 2020 to October 2021
Czeisler, M. E., Czeisler, C. A.
10.1101/2022.07.22.22277899 — Posted: 2022-07-22
Performance evaluation of the LumiraDx SARS-CoV-2 & Flu A/B Test in diagnosing COVID-19 and influenza in patients with respiratory symptoms
Ellis, J. E., Guest, P., Lawson, V., Loecherbach, J., Lindner, N., McCulloch, A.
10.1101/2022.07.20.22277845 — Posted: 2022-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).